EDGAR Filing Documents for 0001395064-23-000131

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001395064-23-000131

Filing Date

2023-10-18

Accepted

2023-10-18 06:21:58

Documents

Period of Report

2023-10-18

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	form6k-2_101823.htm	6-K	11771
2	EX-99.1	irishtaxsettlement.htm	EX-99.1	10061
3	GRAPHIC	irishtaxsettlement001.jpg	GRAPHIC	181085
4	GRAPHIC	irishtaxsettlement002.jpg	GRAPHIC	202037
5	GRAPHIC	irishtaxsettlement003.jpg	GRAPHIC	175978
	Complete submission text file	0001395064-23-000131.txt		793150

Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668

Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111

TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 231330878
SIC: 2834 Pharmaceutical Preparations